US equities |
MU $878.84 ▼-5.63% NVDA $214.13 ▼-1.43% TSLA $354.72 ▼-2.13% AAPL $343.46 ▲+0.43% META $709.33 ▼-3.72% MSFT $529.05 ▼-1.93% SPCX $146.03 ▼-1.74% AMD $528.75 ▼-5.95%
FinancialContent

Articles published by Parabilis Medicines, Inc.

News headline image
Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
From Parabilis Medicines, Inc.
Via GlobeNewswire
Tickers PBLS
News headline image
Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
From Parabilis Medicines, Inc.
Via GlobeNewswire
Tickers PBLS
News headline image
Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
From Parabilis Medicines, Inc.
Via GlobeNewswire
Tickers PBLS
News headline image
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Parabilis Medicines, Inc.
Via GlobeNewswire
Tickers PBLS
News headline image
Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors
From Parabilis Medicines, Inc.
Via GlobeNewswire
Tickers PBLS
News headline image
Parabilis Medicines Announces Pricing of Upsized Initial Public Offering
From Parabilis Medicines, Inc.
Via GlobeNewswire